Shenyu Wang
Beijing, 100071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain.
Journal: Experimental hematology & oncology
Published: April 02, 2025
Global, regional, and national anemia burden among women of reproductive age (15-49 years) from 1990 to 2021: an analysis of the Global Burden of Disease Study 2021.
Journal: Frontiers in nutrition
Published: March 06, 2025
Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study.
Journal: Annals of hematology
Published: February 21, 2025
Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up.
Journal: Frontiers in immunology
Published: May 22, 2024
Is radiotherapy still the optimal initial choice for patients with early-stage low-grade follicular lymphoma in the modern era? A population-based study.
Journal: Annals of hematology
Published: January 14, 2024
Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: A population-based study.
Journal: Cancer medicine
Published: December 06, 2023
Increased risk of nonrelapse mortality post T-cell-replete haploidentical stem cell transplantation in patients with recurrence of acute graft-versus-host disease.
Journal: Hematological oncology
Published: December 04, 2021
Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy.
Journal: Cytotherapy
Published: April 17, 2020
IFN-γ and TNF-α aggravate endothelial damage caused by CD123-targeted CAR T cell.
Journal: OncoTargets and therapy
Published: February 18, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026